S_ary We report here the use of multiplex fluorescent polymerase chain reaction (PCR) for quantitative allele loss detection using microsatellites with 2-5 base pair repeat motifs. Allele loss of APC, DCC, p53 and RBI in colorectal tumours has been reported previously using a variety of methods. However, not all workers used intragenic markers. We have used microsatellite polymorphisms which map within, or are closely linked to, these tumour-suppressor gene loci in order to determine whether these loci are indeed the targets for alteration in colorectal cancer. In addition, we have assayed two other tumour-suppressor genes, WT) and NF1, to see whether they play a role in colorectal carcinogenesis. The putative metastasis-suppressor gene, NM23, was also investigated since there have been conflicting reports about its involvement in colorectal carcinogenesis. Allele loss was detected at the DCC (29%), p53 (66%), RBI (50%) and NFI (14%) loci and in theAPC/MCC region (50%), but not at the WTI or NM23 loci. These rapid, and mostly gene-specific, fluorescent multiplex PCR assays for allele loss detection could be modified to devise a single molecular diagnostic test for the important lesions in colorectal cancer.
The progression of a colorectal tumour is a multistage process involving activation of oncogenes and inactivation of tumour-suppressor genes (Fearon & Vogelstein, 1990 ). If we are to establish which are the most important genes in this pathway we must be able to assay specific genes rapidly and easily.
The p53, adenomatous polyposis coli (APC), deleted in colorectal cancer (DCC) and retinoblastoma (RB)) genes are tumour-suppressor genes which are implicated in this pathway. To lose their suppressing effect, tumour-suppressor genes have to undergo allele loss to uncover recessive mutations in the remaining allele. Although loss of heterozygosity is accepted to be a later event than mutation of a tumoursuppressor gene, it is more widely studied because it is easier to assay. Most tumour-suppressor genes display a wide array of mutations and therefore require more time-consuming assays. Allele loss assays are used to determine which chromosome sites have undergone reduction to homozygosity. There have been several reports on APC (5q21), DCC (18q21) and p53 (17pl3) allele loss in colorectal tumours, but not all used specific intragenic sequence polymorphisms to determine whether the tumour-suppressor gene itself had been lost. In almost all cases where intragenic restriction fragment length polymorphisms (RFLPs) have been used detection involved the use of a radiosotopic Southern blot analysis. This type of assay requires large amounts of goodquality DNA (and is therefore not suitable for the study of paraffin-embedded specimens), is time consuming and is usually subjective rather than quantitative. Therefore rapid and reliable gene-specific quantitative PCR assays for allele loss need to be developed in order that the true significance of suppressor genes involved in colorectal cancer can be confirmed on large series.
Most previous workers assessed the p53 gene region for allele loss using Southern blot analysis. The frequencies of allele loss of the p53 region found using this method ranged from 48% (Lothe et al., 1992) to 68% (Meling et al., 1993) . RFLP probes and Southern blot analysis of the APC/MCC region yielded allele loss frequencies of 31% (Neuman et al., 1991) to 48% (Ashton-Rickardt et al., 1989) . Again, most previous work on allele loss of DCC was done using RFLP probes and Southern analysis, with frequencies ranging from 66% (Barletta et al., 1993) to 75% (Ookawa et al., 1993) . However, a study using the same primers [DCC (1)] as our study, which amplify an intragenic region, revealed an allele loss frequency of only 33% (Huang et al., 1993) .
Involvement of the RBI gene (13ql4) in colorectal cancer has been shown by previous studies. Meling et al. (1991) showed that RBI was altered in 35% of cases, using an intragenic probe, but noted that both amplification and deletion occurred. Ookawa et al. (1993) used markers at the RB) locus and found allele loss in 46% of cases.
The importance of the NM23 gene (17q22) in colorectal carcinogenesis is controversial since both allele loss and protein overexpression have been found, and other workers have found no evidence of allele loss. Using RFLP probes allele loss of NM23 was shown in 52% of cases by Cohn et al. (1991) , but in only 13% of cases by Wang et al. (1993) . However, Whitelaw and Northover (1994) found no evidence of allele loss of NM23 in 34 informative cases. Further studies of NM23 expression have confounded the picture since increased expression of NM23 has been found in 80-88% of colorectal tumours (Haut et al., 1991; Myeroff & Markowitz, 1993) . Evidence for mutational activation, as with p53, has not been found (Myeroff & Markwitz, 1993; Wang et al., 1993) .
There are no reports to our knowledge on allele loss of the Wilms' tumour gene WTI (lIp13) or the neurofibromatosis type 1 gene NFI (17q 1), which are both tumour-suppressor genes, in colorectal cancer. The NFI gene product is involved in the ras signal transduction pathway and could therefore be of importance in other cancers. The NFl product has GTPase-activating protein (GAP) activity, which can downregulate ras. There has been one study of NFI in colorectal cancer, which looked at mutations of the gene (Li et al., 1992) , and in the one case of mutated NFI found the mutant protein had 200-400 times reduced GAP activity.
The drawbacks to the use of RFLPs in allele loss studies include the amount and quality of DNA required and the length of time to produce results when using radioisotopic detection methods. Microsatellites are DNA sequence polymorphisms which exhibit length polymorphisms and are usually highly informative (Weber & May, 1989) . Allele loss can be detected using microsatellites in a radioactive PCR assay (Jones & Nakamura, 1992; Gruis et al., 1993 DNA extraction DNA was extracted using a proteinase K digestion method as described by Bell et al. (1991) .
Primer sequences
The APC (1) primers amplify a CA repeat motif at the D5S299 locus proximal to, and linked to, APC (van Leeuwen et al., 1991) . The sequences were 5'-GTAAGCAGGACAAG-ATGACAG and 5'-GCTATTCTCTCAGGATCITTG (van Leeuwen et al., 1991) and give products of 156-182bp. The APC (2) primers amplify a CA repeat at the D5S82 locus, which is proximal to APC (Breukel et al., 1991) . The sequences were 5'-CCCAATTGTATAGATFTTAGAAGTC and 5'-ATCAGAGTATCAGAATTTCT (Breukel et al., 1991) and give products of 169-179bp. The p53 (1) primers amplify a CA repeat at the p53 locus (Jones & Nakamura, 1992) . The sequences were 5'-AGGGATACTATTCAGCCC-GAGGTG and 5'-ACTGCCACTCCTTGCCCCATTC (Jones & Nakamura, 1992) and give products of 103-135 bp.
The p53 (2) primers amplify an AAAAT 5 bp repeat in the first intron of the p53 gene (Futreal et al., 1991) . The reverse primer sequence was 5'-AACAGCTCCTTT-lAATGGCAG (Futreal et al., 1991) , but the forward primer (5'-GAATC-CGGGAGGAGGTTG) was designed from the p53 genomic DNA sequence in order to develop a simple PCR assay. This marker gives products of 140-175 bp. The DCC (1) primers amplify a TA repeat in an intron of DCC (Fearon et al., 1990; Risinger & Boyd, 1992) . The sequences were 5'-TCCCTCTAGAAATTGTGTG and 5'-TGACTITATCTCATTGGAG (Risinger & Boyd, 1992) and gives products of 106-160 bp. The DCC (2) primers are an alternative set of amplimers which amplify the same TA repeat as the DCC (1) primers. The sequences were 5'-GATGACATlTTTCCCTCTAG and 5'-GTGGTTATTGCC-TTGAAAAG (Huang et al., 1992) and give products of 150-210 bp.
The RBJ primers amplify a CTTT(T) 4-5 bp repeat in intron 20 of the RBI gene (Yandell & Dryja, 1989 ). The sequences were 5'-CTCCTCCCTACT-TACTTGT (Huang et al., 1992) and 5'-AATlTAACAAGGTGTGGTGGTACACG (Onadim et al., 1992) and give products of 266-306bp. The WTI primers amplify a CA repeat in the 3' untranslated region of WTJ (Haber et al., 1990) . The sequences were 5'-AATGAGACTTACTGGGTGAGG and 5'-TTACACAG-TAATTITCAAGCAACGG (Haber et al.. 1990 ) and give products around 144 bp.
The NM23-HI primers amplify a CA repeat at the NM23-HI locus (Hall et al., 1992) . The sequences were 5'-TT-GACCGGGGTAGAGAACTC and 5'-TCTCAGTACTITC-CCGTGACC (Hall et al., 1992) and give products of 94-104 bp.
The NFI primers amplify a CA repeat in intron 38 of the NFl gene (Lizaro et al., 1993) . The sequences were 5'-CAGAGCAAGACCCTGTCT AND 5'-CTCCTAACATTT- ATTAACCTTA (Lizaro et al., 1993) and give products of 171-187 bp.
Primer synthesis, labelling and purification For each primer pair one primer only was fluorescently labelled. This was so that only one DNA strand was detected on the gel, which made interpretation easier. All primers were synthesised on a model 391 DNA synthesiser (Applied Biosystems, Foster City, CA, USA). Using red (rox) as the size standard colour we had three colours available (green, blue and yellow), with the choice of five fluorochromes (Applied Biosystems). Yellow primers were produced by using the tamra fluorochrome (dye-NHS ester), the blue primers were produced using either 5'fam (dye-NHS ester) or 6'fam amidite, and the green primers were produced using using either joe (dye-NHS ester) or hex amidite. Non-fluorescent primers Non-fluorescent primers required no purification before use in PCR and were stored in concentrated ammonia at -20'C. The ammonia was removed prior to each PCR by evaporation in a vacuum desiccator.
Fluorescent primers Two different methods were used to fluorescently label the primers using either dye-NHS esters or dye-amidites. 1. Dye-NHS ester method. This method was as described in Cawkwell et al. (1993 Multiplex PCR Multiplex PCR assays were designed on the basis that coamplified products would be distinguished either by colour or by size range. The method for multiplex PCR was the same as above except that more than one set of primers were added to the same tube.
Polyacrylaunide gel electrophoresis PCR products were analysed on 6% polyacrylamide (Gelmix-6, Gibco BRL, Uxbridge, Middlesex, UK) denaturing gels in 1 x TBE buffer in a model 373A (four filter wheel) automated fluorescent DNA sequencer (Applied Biosystems), which is a four-colour detection system. One microlitre of each PCR reaction was combined with 4 g of formamide and 0.5 pi of a fluorescent size marker (GS2500P, Applied Biosystems). This mix was denatured for 3 min at 90-C, after which 5 il was loaded into each well on the prewarmed gel.
The tumour DNA samples were loaded 5 min after the normal samples so that any lane-to-lane spillage would not affect the subsequent quantitation. The internal size standard for each sample enables staggered loading to be carried out. The gel was run at 30 W and 40C for 4 h except when using the RBI primers, which required 6 h. While the samples were undergoing electrophoresis the fluorescence detected in the laser cnning region was collected and stored using the Genescan Collection software (Applied Biosystems).
Data analysis
The fluorescent gel data collected during the run were automatically analysed by the Genescan Analysis program (Applied Biosystems), using the appropnate dye matrix, at the end of the run. Each fluorescent peak was quantitated in terms of size (in base pairs), peak height and peak area.
Calculation of allele ratios Allele ratios were caculated as described in Cawkwell et al. (1993) . The siz of the two alleles for heterozygous cases were assigned according to the two peaks of greatest heght in the normal sample. The values for peak area of the two alleles in the paired normal and tumour samples were used to assign a figure for allele loss. In the case of DCC we had two different sets of primers available to amplify the same TA repeat, but we found that the DCC (2) primers, which give longer products, were much easier to interpret than the DCC (1) primers, and so the DCC (2) primers will be used in the future.
Representative examples of the electropherograms are shown in Figures 1 and 2 .
Both the dye-NHS ester-and the dye-amidite-labelled primers worked well, but the amidite dyes required less manipulation. The tamra dye was consistently found to be less intense than any of the blue or green dyes.
We observed prferential amplification of shorter products over larger products (Figure 1 ). This affected the success of some multiplex designs since markers which gave products of shorter length would be overamplified in relation to markers which gave longer length products. This was especially evident with the NM23 primers, but overamplification could usually be corrected by diluting an aliquot of the PCR product.
Some microsatellites produce 'stutter bands', which are PCR artefacts (Litt, 1991; Hauge & Litt, 1993) and can make interpretation of results difficult from autoradiographs. The fluorescence-based system overcame this problem in most cases. The p53 (1) and DCC (1) markers, which are 2bp repeats, were the most problematic in terms of interpretation of results owing to excess stutter bands. The longer 4-5 bp repeat markers were not prone to this artefact and thus the alleles were much easier to distinguish.
The results are shown in Table I . The use of microsatellites for allele loss studies facilitates the identification of loci where microsatellite instability (Aaltonen et al., 1993; Ionov et al., 1993; Thibodeau et al., 1993) has occurred, and with the use of our fluorescence detection method these are easily recognised (L. Cawklwell et al., manuscript in preparation). The finding of microsatellite instability meant that such loci were designated uninformative and thus the total number of informative cases was reduced. The allele imbalance frequency was calculated as [Al/ (Al + N)] x 100%, i.e. excluding all loci which were either homozygous or affected by microsatellite instability. Our microsatellite instability results will be further described in a separate paper (L. Cawkweli et al., manuscript in preparation).
Where two markers were used for a region we found no discordance between the two results where both markers were informative.
The frequencies of allele imbalance found were as follows:
APC/MCC region, 50% (8/16); p53, 66% (10/15); DCC, 29% (5/17); RB), 50% (7/14); WTI, 0% (0/10); NFI, 14%
(2/14); NM23, 0% (0/14).
Diwoss
We have used fluorescent multiplex PCRs in order to increase throughput for quantitating allele imbalance at seven suppressor loci in colorectal tumours. Our frequencies for allele imbalance of the p53 and RBI loci are similar to the finngs of others using RFLP probes and Southern blot analvsis. The use of our fluorescent microsatellite assay has enabled us to easily detect microsatellite instability. This caused problems with the allele imbalance study, since such loci had to be classed as uninformative. However, the assay does enable us to assess these two types of alteration simultaneously.
Multiplex design in future will take into account the preferential amplification of short products over long products. To counteract this, the shortest products could be labelled with the tamra dye since this is the weakest fluorescing dye. Alternatively, to counteract this effect, the separate amplification of short products and long products would enable the optimisation of both. The products could then be mixed and co-loaded into a single lane on the gel.
The use of fluorescent multiplex PCR for allele imbalance assays enabled us to assess several suppressor gene loci simultaneously. The most frequently occurring lesions in colorectal cancer will now be studied in an extended series with accompanying clinical and follow-up data to see whether any alteration, or specific combination of alterations, correlates with clinical features or prognosis. We will then attempt to devise a rapid and robust fluorescent multiplex PCR assay for allele imbalance, preferably in a single tube, to assess all of these important lesions simultaneously. Such a diagnostic test could be important in screening, prognosis and therapy in colorectal cancer, and in a modifed form in other tumours.
In conclusion, in this preliminary study we have used rapid and quantitative fluorescent multiplex PCR assays to detect allele imbalance at several tumour-suppressor loci simultaneously, using microsatellite markers of 2-5 bp repeat motifs, in order to identify the specific genes which undergo alteration most frequently in sporadic colorectal tumours. These assays also identified microsatellite instability.
